The 2026 IoT Breakthrough Award recognizes the breakthrough innovation of Revenera’s IoT Monetization Platform, which helps device companies transitioning to a software-based model grow recurring ...
PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...
Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback